We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » International Drugmakers Plan for Higher Costs as Brexit Looms
International Drugmakers Plan for Higher Costs as Brexit Looms
Testifying before a UK House of Commons committee last month, international pharmaceutical companies said they are already hedging their bets when it comes to the real-world consequences of Brexit, making preparations for new hurdles in manufacturing and duplications of batch release testing that could cost millions of pounds per year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor